KRONOXKronox Lab Sciences Limited
Chemicals · Specialty Chemicals · NSE · as of 2026-10-26 (delayed ~30 min in market hours)
Kronox Lab Sciences Limited manufactures and sells fine chemicals, inorganic chemicals, phosphates, and metallic chemicals in India and internationally. The company provides bulk reagents comprising ACS reagents, as well as LR, AR, and GR reagents; bulk ingredients that includes oral care, pharmacopoeia, food and nutraceutical, personal care and cosmetics, and veterinary pharma and animal health; and specialty chemicals, such as tartrates, citrates, hypophosphites, phosphates, hydroxides, EDTA and derivatives, ultra high purity chemicals, custom specification, and specialty anhydrous, as well as heat treatment, quenching, eutectic salt. Kronox Lab Sciences Limited was incorporated in 2008 and is based in Vadodara, India.
Price & Volume
Loading chart…
Key Ratios
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
None of the 16 pattern scanners currently detects a setup on KRONOX — signals appear here automatically when one forms (checked on every data refresh). The Trade Plan on the right always provides stop-loss and target levels regardless.
The picture
- • Revenue growth: 16.9% YoY
- • Profit growth: 17.6% YoY
- • ROE: 23.8%
- • Price vs SMA200: above
- • Golden cross setup: SMA50 above SMA200
- • Supertrend: bullish
Bull case
- • Revenue growth: 16.9% YoY
- • Profit growth: 17.6% YoY
- • ROE: 23.8%
- • Price vs SMA200: above
Bear case
- • Promoter holding: 11.7%
- • Dividend yield: 0.30%
- • MACD: bearish
- • Price vs EMA21: below
Key risks
- • Elevated volatility / drawdown profile — size positions accordingly
- • Promoter holding: 11.7%
- • Dividend yield: 0.30%
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹11.75). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.